FCM
MDLN

Farallon Capital Management’s Medline Inc MDLN Stock Holding History

Farallon Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260,000
Closed -$10.9M – 203
2025
Q4 		$10.9M Buy
+260,000
New +$11M 0.05% 72

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Farallon Capital Management's MDLN Position: Q1 2026 in Review

Farallon Capital Management sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 260,000 shares — an estimated $10.9M sold.

Farallon Capital Management first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $10.9M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Farallon Capital Management reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
  • Farallon Capital Management sold 260,000 Medline Inc shares in Q1 2026, an estimated $10.9M.
  • Farallon Capital Management first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
  • Farallon Capital Management's Medline Inc position peaked at $10.9M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.